Our Resources

ObvioHealth, a global Virtual Research Organization (VRO), announces its next generation platform offering enhanced remote patient monitoring capabilities for the company’s end-to-end decentralized clinical trial solutions.

ObvioHealth, a global Virtual Research Organization(VRO), announces it has raised $31 million in its latest round of financing. The round was led by two new partners: Dedalus Group, an international healthcare IT and diagnostic software provider, leader in Europe and backed by Ardian, and Novotech Health Holdings Pte. Ltd.(“Novotech”), Asia Pacific’s highest revenue biotech-specialistCRO in 2020.

Despite the industry efforts to refine the processfor remote patient monitoring and outcomes measurement, accurate, complete real-worlddata is tough to capture. Our presentation offers insider industry knowledgegained from DCTs that employed next-gen ePRO and audio/image capture technologyto deliver reliable data sets.

At MAGI 2020, we spoke on the many advantages of 'going virtual.' Our presentation revolves around one critical observation: not every trial can go virtual, but every trial can benefit from implementing virtual elements. Virtual clinical trials make for happier, engaged patients who produce better data. Our patient-centric DCTs are evidence.